• Issues pertaining to the self-insurance industry and stop-loss insurance; issues pertaining to captive insurance election under IRC 831 (b)
• Issues related to surprise medical billing Issues related to drug pricing H.R.861 - End Surprise Billing Act of 2019 S.1531 - Stopping The Outrageous Practice of Surprise Medical Bills Act of 2019 S.1266 - Protecting Patients from Surprise Medical Bills Act S.474 - Stopping the Pharmaceutical Industry from Keeping drugs Expensive (SPIKE) Act of 2019 S.1895 - Lower Health Care Costs Act H.R.4223 - Protecting Patients from Surprise Medical Bills Act H.R.3502 - Protecting People from Surprise Medical Bills Act H.R.3630 - No Surprises Act H.R.3784 - Air Ambulance Affordability Act of 2019 H.R.3 - Elijah E. Cummings Lower Drug Costs Now Act

Duration: February 1, 2019 to April 30, 2020

General Issues: Insurance, Health Issues, Taxation/Internal Revenue Code

Spending: about $130,000 (But it's complicated. Here's why.)

It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.

Agencies lobbied since 2019: U.S. Senate, House of Representatives, Treasury - Dept of

Affiliated organizations: Self-Insurance Institute of America, Inc.